Zhe Sha, Harvard Medical School, USA
Its my real honor to be part of this great conference. I had a truly rewarding experience meeting with many experts in the field.
Jamal Abdel-Halim, Director, Biomarkers, USA
It was my pleasure to participate and speak in this important meeting. I wish we work together again.
Following on from the success of last year, OMICS Group’s 3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials is set to take centre stage once more in Hyderabad India on October 27-29, 2014.
Over the last couple of decades, advances in biomedical science have generated more new and complex medicines to treat a broader range of diseases and conditions than ever before. The number of people taking medications has increased dramatically, and, as a result, governments, patient groups and health advocates are demanding stronger regulatory practices and procedures, to assure the safety of medicines before and after they reach the market.
Hence, as the regulatory landscape continues to evolve it is crucial that you are keeping abreast of the changes impacting the drug safety industry to ensure that your pharmacovigilance strategies are robust and geared to compliance. In addition to this effective risk management and minimisation efforts and comprehensive benefit: risk analysis of drugs must lay the foundations for a strong drug safety strategy.
This educational 3 day conference provides a unique platform for you to address the practical approaches you can take to mitigate risks and maximise patient safety. A tailored conference will give you the opportunity to share knowledge and expertise and will provide unparalleled networking opportunities with a large number of professionals in this industry sphere.
Pharmacovigilance and its Challenges
Role of Clinical Trials
Clinical Trials on Diseases
Adverse Drug Reactions
Pharmacokinetics and Pharmacodynamics
Pharmacy Practices and its Challenges
Risk Management: New Approaching Paradigm for Pharmacovigilance
Clinical Research and Statistics
Strategies for Growth in Pharma Environment
Good Pharmacovigilance Practice and Pharmacoepidemiology
Case Report in Clinical Trials